Your browser doesn't support javascript.
loading
Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment.
Obrecht-Sturm, Denise; Pfaff, Elke; Mynarek, Martin; Bison, Brigitte; Rodehüser, Martina; Becker, Martina; Kietz, Silke; Pfister, Stefan M; Jones, David T; Sturm, Dominik; von Deimling, Andreas; Sahm, Felix; Kortmann, Rolf-Dieter; Schwarz, Rudolf; Pietsch, Torsten; Fleischhack, Gudrun; Rutkowski, Stefan.
Affiliation
  • Obrecht-Sturm D; Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. d.obrecht-sturm@uke.de.
  • Pfaff E; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Mynarek M; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Bison B; Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Rodehüser M; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Becker M; Diagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
  • Kietz S; Pediatric Hematology and Oncology, Hospital Kassel, Kassel, Germany.
  • Pfister SM; Pediatric Hematology and Oncology, Medical Department, Frankfurt am Main, Germany.
  • Jones DT; Department for Pediatric Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
  • Sturm D; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • von Deimling A; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Sahm F; Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Kortmann RD; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Schwarz R; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Pietsch T; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Fleischhack G; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Rutkowski S; Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
J Neurooncol ; 166(2): 359-368, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38253790
ABSTRACT

PURPOSE:

To provide a treatment-focused review and develop basic treatment guidelines for patients diagnosed with pineal anlage tumor (PAT).

METHODS:

Prospectively collected data of three patients with pineal anlage tumor from Germany was combined with clinical details and treatment information from 17 published cases.

RESULTS:

Overall, 20 cases of PAT were identified (3 not previously reported German cases, 17 cases from published reports). Age at diagnosis ranged from 0.3 to 35.0 (median 3.2 ± 7.8) years. All but three cases were diagnosed before the age of three years. For three cases, metastatic disease at initial staging was described. All patients underwent tumor surgery (gross-total resection 9, subtotal resection/biopsy 9, extent of resection unknown 2). 15/20 patients were alive at last follow-up. Median follow-up for 10/15 surviving patients with available follow-up and treatment data was 2.4 years (0.3-6.5). Relapse was reported for 3 patients within 0.8 years after diagnosis. Five patients died, 3 after relapse and 2 from early postoperative complications. Two-year-progression-free- and -overall survival were 65.2 ± 12.7% and 49.2 ± 18.2%, respectively. All 4 patients who received intensive chemotherapy including high-dose chemotherapy combined with radiotherapy (2 focal, 2 craniospinal [CSI]) had no recurrence. Focal radiotherapy- and CSI-free survival rates in 13 evaluable patients were 46.2% (6/13) and 61.5% (8/13), respectively.

CONCLUSION:

PAT is an aggressive disease mostly affecting young children. Therefore, adjuvant therapy using intensive chemotherapy and considering radiotherapy appears to comprise an appropriate treatment strategy. Reporting further cases is crucial to evaluate distinct treatment strategies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pineal Gland / Pinealoma / Brain Neoplasms / Supratentorial Neoplasms Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Humans / Infant Language: En Journal: J Neurooncol Year: 2024 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pineal Gland / Pinealoma / Brain Neoplasms / Supratentorial Neoplasms Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Humans / Infant Language: En Journal: J Neurooncol Year: 2024 Type: Article Affiliation country: Germany